Insulin Sensitivity & Metabolic Health Stack
- Category
- Weight Loss & Metabolism
- Purpose
- Blood Sugar Regulation & Metabolic Optimization
- Peptides
- MOTS-cBPC-157Semaglutide
Overview
A metabolic health stack addressing insulin resistance from multiple angles. Semaglutide (GLP-1 agonist) handles the incretin/insulin axis and appetite suppression. MOTS-c activates AMPK to improve peripheral insulin sensitivity and fat oxidation. BPC-157 supports GI health (critical for metabolic function) and modulates the dopamine-reward pathways that drive food-seeking behavior.
An FDA-approved appetite and blood-sugar medication is paired with two supporting peptides that target fat-burning and gut health, tackling weight and metabolism from multiple directions.
Compounds in this stack
MOTS-c Research
A peptide made inside your own mitochondria that mimics the metabolic benefits of exercise — improving energy and blood sugar control.
BPC-157 Research
A widely studied 'healing peptide' derived from stomach protein. Popular for helping the body repair muscle, tendon, and gut tissue faster.
Semaglutide FDA Approved
The FDA-approved GLP-1 behind Ozempic and Wegovy. Reduces appetite, blood sugar, and heart disease risk.
⚠️ This page describes a combination of compounds that are, with few exceptions, not approved by the FDA for any use. It records protocols described in research and community sources. It is not a recommendation, not a prescription, and not medical advice. Combining compounds multiplies the unknowns rather than adding them. Do not act on anything here without a qualified healthcare professional who knows your history.